Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
Public ClinicalTrials.gov record NCT01007110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
DHA, a type of fatty acid, is important in early development, both in terms of reproductive physiology of gestation and in postnatal behavioral and cognitive function. In adults, DHA has been shown to lower triglycerides and is important to cardiovascular health and autonomic control, lowering heart rate and blood pressure and increasing heart variability. Little is known about how fatty acids impact cardiac control in infants, children or the fetus. Our hypothesis is that maternal DHA supplementation (600 mg/day) will lower fetal HR and increase fetal HRV.
Study identification
- NCT ID
- NCT01007110
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 67 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 16 Years to 35 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2009
- Primary completion
- Apr 30, 2011
- Completion
- Jun 30, 2011
- Last update posted
- Jun 8, 2014
2009 – 2011
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pregnancy trials
Other public records listing Pregnancy. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792837: An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being Recruiting
- NCT07776457: Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management Not yet recruiting
- NCT05656378: A Repository to Study Host-Microbiome Interactions in Health and Disease Recruiting
- NCT06199154: Induction of Labor in Morbidly Obese Patients Recruiting
- NCT07213284: Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial Recruiting
- NCT06259097: Different Medications to Induce Labor Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01007110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2014 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01007110 live on ClinicalTrials.gov.